Yes variants in GIPR, FTO, and MC4R, and TCF7L2 are associated with differential GLP-1 response
Am J Clin Nutr 2009 , 89 , 7176 [8] Manta-Vogli, P.D
No GI breakdown Consistent systemic delivery SQ or IM administration 1
Further clinical trials are required to define the benefits and risks of taking a GLP-1 drug in the pouch population
Compounded medications do not undergo pre-market review or an FDA-approval process
Comparing GLP-1 Therapies: Semaglutide, Ozempic, Wegovy, and Mounjaro at Vive Ageless Weight Loss Center Compounded semaglutide is a custom-made version of the drug, prepared by compounding pharmacies without FDA approval, while Ozempic, Wegovy, and Mounjaro are FDA-approved medications for managing diabetes and obesity